Latest Insights on CRSP
The #1 Breakthrough Biotech Stock for 2023 November 1, 2022 Investment Opportunities, Technology, Trending, Winning Investor Daily
CRISPR Therapeutics is dedicated to 2 things: genetics research and saving lives. find out why this biotech stock is our #1 pick for 2023!
Great Glimmers Of Positivity; Hyzon’s Prime Time Destiny July 15, 2022 Great Stuff
Friday Feedback: The “Don’t Worry, Be Happy” Edition Here’s a little e-zine I wrote. You might want to read it note for note. Don’t worry. Be happy. In every market we have some trouble. But when you worry, your losses double. Don’t worry. Be happy. Great Ones, I have to thank you. Seriously. There’s no […]
CRISPR Capers, Hyzon Hot Takes & GOGO Wifi Rangers October 8, 2021 Great Stuff
Genome What I’m Sayin’? At long last … the day has come! ‘Round here, Fridays are filled with Reader Feedback from start to finish — like a feast of meaty market morsels, delectable investing questions and awkward food analogies. It’s once again time to hold my nose and dive into the Great Stuff inbox to […]
Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance June 28, 2021 Great Stuff
Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]
This Super Asset Dominated the Past 15 Years July 11, 2019 Investing, Stocks, Winning Investor Daily
Maybe past performance won’t tell us exactly what will happen in the future. But it does show us that owning this asset is the right thing to do.MEET OUR EXPERTS
Editor of Alpha Investor
Investment Strategist
Editor of Strategic Fortunes and three elite services
CEO of Banyan Hill
Director of Investment Research
Research Analyst
Director of VIP Services
Editor of One Trade and Precision Profits
